Efficacy News and Research

RSS
MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

MicrosensDx collaborates with Imperial researchers to develop groundbreaking sepsis test

Study highlights limited evidence for antidepressants in treating pain in older adults

Study highlights limited evidence for antidepressants in treating pain in older adults

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

ESMO 2024: Promising results in immunotherapy and antibody drug conjugates for gynecological cancers

Novel delivery platform enhances effectiveness of cancer immunotherapy and reduces side effects

Novel delivery platform enhances effectiveness of cancer immunotherapy and reduces side effects

Review highlights mitochondrial dysfunction in cholestatic liver injury

Review highlights mitochondrial dysfunction in cholestatic liver injury

Combination immunotherapy yields 10-year survival for metastatic melanoma patients

Combination immunotherapy yields 10-year survival for metastatic melanoma patients

Laughter is as good as eye drops in soothing dry eyes, study finds

Laughter is as good as eye drops in soothing dry eyes, study finds

Early data shows mRNA-4359 may benefit patients with advanced solid cancers

Early data shows mRNA-4359 may benefit patients with advanced solid cancers

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

New cancer drug shows encouraging results in Phase I/II trial

New cancer drug shows encouraging results in Phase I/II trial

Scientists develop novel technique to combat T cell exhaustion

Scientists develop novel technique to combat T cell exhaustion

Evolution of vaccine adjuvants from empirical discovery to rational design

Evolution of vaccine adjuvants from empirical discovery to rational design

Study sheds light on potential demand for psilocybin-assisted therapy for depression in the U.S.

Study sheds light on potential demand for psilocybin-assisted therapy for depression in the U.S.

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

PPARs and PROTACs: A new strategy in cancer therapeutics

PPARs and PROTACs: A new strategy in cancer therapeutics

Breakthrough study sheds light on mechanisms behind the spread of gastric cancer to the peritoneum

Breakthrough study sheds light on mechanisms behind the spread of gastric cancer to the peritoneum

WHO adds MVA-BN vaccine to prequalification list as first vaccine against mpox

WHO adds MVA-BN vaccine to prequalification list as first vaccine against mpox

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

ISM2196: A promising AI-developed WRN inhibitor for advanced metastatic cancers

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

No difference in health outcomes between 24-hour and 15-hour oxygen therapy

No difference in health outcomes between 24-hour and 15-hour oxygen therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.